Milestone Pharmaceuticals Inc. — Director's Dealing 2020

Jun 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2020-06-05

Reporting Person: Hasija Amit (CFO & EVP of Corp. Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-05	Employee Stock Option (right to buy)	$3.74	A	115000	Acquired	2030-06-05	Common Shares (115000)	Direct

Footnotes

F1: The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.